Exchange: OTC·Updated 03:53 PM EDT

NAVB Navidea Biopharmaceuticals Inc

$0.0001
$0.0009
(90.00%)
Today
Mkt Cap$100,084.00
Vol199,887.00

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Columbus, OH.
54

Neutral Sentiment

How do you feel about NAVB?

Advertisement|Remove ads.